Ligand · QJ9
QJ9 · 1-{(3S)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl}-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one
QJ9, 1-{(3S)-1-[4-(1-benzofuran-2-yl)pyrimidin-2-yl]piperidin-3-yl}-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (C26 H25 N5 O2, 439.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- QJ9
- Formula
- C26 H25 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
QJ9 in 2 structures; the first of them:
- 3QJ9 · Crystal structure of fatty acid amide hydrolase with small molecule inhibitor · QJ9 A600 · binds MET191, LEU192, SER193, PHE194, ILE238, GLY239, GLY240, SER241 and 14 more
- 3QJ9 · Crystal structure of fatty acid amide hydrolase with small molecule inhibitor · QJ9 A600 · binds MET191, LEU192, SER193, PHE194, ILE238, GLY239, GLY240, SER241 and 14 more
Residues it binds most
LEU 4, PHE 4, GLY 4, ILE 4, MET 4, SER 4, THR 4, TRP 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.